Anakinra is a recombinant, nonglycosylated human interleukin-1 receptor antagonist (IL-1Ra). The difference between anakinra and the native human IL-1Ra is that anakinra has an extra methionine residue at the amino terminus. It is manufactured by using the E. coli expression system. Anakinra is composed of 153 amino acid residues. FDA approved on November 14, 2001.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1402z | Mouse Anti-IL1RN Recombinant Antibody (clone 8C2) | WB, IHC | Mouse IgG2b |
MOB-0238CT | Recombinant Mouse anti-Human IL1RN Monoclonal antibody (B82C7E22) | ELISA |
CAT | Product Name | Application | Type |
---|---|---|---|
NEUT-1305CQ | Mouse Anti-IL1RN Recombinant Antibody (clone CBL417) | ELISA, Neut | Mouse IgG2a |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-1800 | Rabbit Anti-IL1RN Recombinant Antibody (clone DS1800AB) | WB, IHC, ICC, IP, FC | Rabbit IgG |
There are currently no Customer reviews or questions for TP-085CL. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.